Generic Pharmaceuticals Company for Sale in Ahmedabad, India
For Sale: WHO-GMP certified specialty pharmaceuticals manufacturer generating an average revenue of INR 20 crore.
This transaction has concluded.
Premium Plan
| Established | 10-20 year(s) |
| Employees | 50 - 100 |
| Legal Entity | Private Limited Company |
| Reported Sales | USD 2.55 million |
| Run Rate Sales | USD 1.74 million |
| EBITDA Margin | 20 - 30 % |
| Industries | Generic Pharmaceuticals |
| Locations | Ahmedabad |
| Local Time | 12:59 PM Asia / Kolkata |
| Listed By | Business Owner / Director |
| Status | Active |
Full Sale
Asking Price:
USD
3 million
(Native Currency: INR 260,000,000)
Reason: Director is moving into another pharmaceutical project and would like to sell this company.
Note - ...
View More
Includes physical assets worth
USD
810 thousand
Documents
Teaser
(465.4 KB)
ROC-Verification.pdf
(61.7 KB)
Business Overview
- WHO-GMP certified company that manufactures specialty pharmaceuticals for illness related to cardiovascular disease and central nervous systems.
- We manufacture medicines under own brand name and also undertake contract manufacturing for 12-15 companies.
- Generate 80% of revenue from our own brand and remaining 20% from contract manufacturing.
- We sell our products to 150+ multi-specialty hospitals based in Gujarat and Maharashtra. We also supply medicines on tender basis to the government in both these states.
- Our company was registered in 2011 but we started operations in 2013.
- Every year, our growth rate is between 15% to 25%. Revenue for the last 3 years are INR 22 crore, INR 19 crore and INR 15 crore.
- Our run rate revenue has dropped due to COVID-19. However, in the next 2 years, we project to generate a yearly revenue of INR 30 crore.
- Director of the company has 20 years of experience in this industry.
- We manufacture medicines under own brand name and also undertake contract manufacturing for 12-15 companies.
- Generate 80% of revenue from our own brand and remaining 20% from contract manufacturing.
- We sell our products to 150+ multi-specialty hospitals based in Gujarat and Maharashtra. We also supply medicines on tender basis to the government in both these states.
- Our company was registered in 2011 but we started operations in 2013.
- Every year, our growth rate is between 15% to 25%. Revenue for the last 3 years are INR 22 crore, INR 19 crore and INR 15 crore.
- Our run rate revenue has dropped due to COVID-19. However, in the next 2 years, we project to generate a yearly revenue of INR 30 crore.
- Director of the company has 20 years of experience in this industry.
Products & Services Overview
We manufacture medicines for cardiovascular disease and central nervous systems. We have more than 400 products.
Assets Overview
Land & building, plant & machinery, office equipment and products.
Facilities Overview
We operate out of a company owned facility. The land area is 33,000 sq. ft. with built-up area of 16,000 sq. ft. The entire facility is set-up as per WHO-GMP guidelines.
Capitalization Overview
Not Disclosed
Recent Activity
-
Earlier than 15 daysDirector, Pharmaceuticals, Ahmedabad, Individual Investor / Buyer connected with the Business
-
Earlier than 15 daysManager, Pharmaceuticals, Vancouver, Corporate Investor / Buyer connected with the Business
-
Earlier than 15 daysExecutive, Nutraceuticals Manufacturers, Dubai, Individual Investor / Buyer connected with the Business
Disclaimer: SMERGERS is a regulated marketplace for connecting business sell sides with investors, buyers, lenders and advisors. Neither SMERGERS represents nor guarantees that the information mentioned above is complete or correct. Note that SMERGERS is not liable for any loss, damage, costs, claims and expenses whatsoever arising from transacting with any other user from the website. The final responsibility of conducting a thorough due diligence and taking the transaction forward lies with the users. Please read best practices on SMERGERS.
